StockData
Pelthos Therapeutics Inc. logo

Pelthos Therapeutics Inc. (PTHS) stock

PTHSNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$6.84−0.31 (-4.34%)

Close on Nov 17, 2026Market cap $26.19MP/E –Yield –

Pelthos Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

Pelthos Therapeutics's gross margin for the twelve months ending Jun 30, 2026 was 78.6%. For fiscal 2025 it was 76.3%.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202576.3%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202676.9%–
Q1 FY2026Mar 31, 202684.7%–
Q4 FY2025Dec 31, 202582.2%–
Q3 FY2025Sep 30, 202568.7%–

More Pelthos Therapeutics figures

See a number that looks wrong?